BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34679171)

  • 1. Brain β-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults.
    Buchman AS; Capuano AW; VanderHorst V; Wilson RS; Oveisgharan S; Schneider JA; Bennett DA
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):277-285. PubMed ID: 34679171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.
    Rabin JS; Shirzadi Z; Swardfager W; MacIntosh BJ; Schultz A; Yang HS; Buckley RF; Gatchel JR; Kirn D; Pruzin JJ; Hedden T; Lipsman N; Rentz DM; Black SE; Johnson KA; Sperling RA; Chhatwal JP; ;
    Neurobiol Aging; 2020 Sep; 93():124-130. PubMed ID: 32249013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults.
    Biddle KD; d'Oleire Uquillas F; Jacobs HIL; Zide B; Kirn DR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    Am J Geriatr Psychiatry; 2019 Nov; 27(11):1247-1256. PubMed ID: 31248770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
    Biddle KD; Jacobs HIL; d'Oleire Uquillas F; Zide BS; Kirn DR; Properzi MR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    JAMA Netw Open; 2020 Feb; 3(2):e200121. PubMed ID: 32101313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.
    Gatchel JR; Rabin JS; Buckley RF; Locascio JJ; Quiroz YT; Yang HS; Vannini P; Amariglio RE; Rentz DM; Properzi M; Donovan NJ; Blacker D; Johnson KA; Sperling RA; Marshall GA;
    JAMA Netw Open; 2019 Aug; 2(8):e198964. PubMed ID: 31397865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.
    Yu L; Petyuk VA; Gaiteri C; Mostafavi S; Young-Pearse T; Shah RC; Buchman AS; Schneider JA; Piehowski PD; Sontag RL; Fillmore TL; Shi T; Smith RD; De Jager PL; Bennett DA
    Ann Neurol; 2018 Jul; 84(1):78-88. PubMed ID: 29908079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    Lee SH; Byun MS; Lee JH; Yi D; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    J Alzheimers Dis; 2020; 75(3):767-777. PubMed ID: 32333586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
    Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
    Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
    Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults.
    Buchman AS; Yu L; Klein HU; Zammit AR; Oveisgharan S; Nag S; Tickotsky N; Levy H; Seyfried N; Morgenstern D; Levin Y; Schnaider Beeri M; Bennett DA
    Neurology; 2024 Apr; 102(7):e209223. PubMed ID: 38502899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive decline.
    Jeon SY; Byun MS; Yi D; Jung G; Lee JY; Kim YK; Sohn CH; Kang KM; Lee YJ; Lee DY;
    Psychiatry Clin Neurosci; 2023 Apr; 77(4):205-212. PubMed ID: 36527292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.